Delivery Order SPE2DB24D2205-SPE2DB25FDYMQ

Award Date 2/18/25
Potential Completion Date 2/19/25
Potential Value $2.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA) is for the delivery of RABAVERT rabies vaccine vials with diluents. The contract has a ceiling value of $1,930.30 and an ultimate completion date of April 17, 2024. This is a Firm Fixed Price delivery order contract with no set-aside designation. Amerisourcebergen is a major pharmaceutical distribution company that holds a $999,999,999.00 Indefinite Delivery Contract (IDC)...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, to provide RABAVERT rabies vaccine and diluents to the Defense Logistics Agency (DLA). The contract is a delivery order with a firm fixed price of $9,651.40 and a period of performance through May 8, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of RABAVERT RABIES VACC W-DILUENTS to the Defense Logistics Agency (DLA). The $2,045.08 firm fixed-price delivery order has a completion date of December 12, 2024. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
This federal contract award is a delivery order valued at $2,613.14 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of RABAVERT Rabies Vaccine with diluents, with a period of performance through May 31, 2023. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,550.75, is for the delivery of RABAVERT Rabies Vaccine with diluents. This is a firm fixed-price Delivery Order contract with a completion date of February 19, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,002.20 firm fixed-price delivery order is for the supply of RABAVERT rabies vaccine with diluents. The contract has an ultimate completion date of November 14, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,239.50, is for the supply of RABAVERT rabies vaccine with diluents. The contract has an ultimate completion date of February 26, 2025 and is a firm fixed-price, non-set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,029.44 firm-fixed-price delivery order contract is for the supply of RABAVERT rabies vaccine with diluents. The contract has an ultimate completion date of February 13, 2025 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the supply of RABAVERT rabies vaccine with diluents. The contract has a ceiling value of $1,676.64 and is a delivery order with a firm fixed-price pricing type. The ultimate completion date is February 3, 2025. The contract is awarded by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a...
This federal contract award is for the delivery of RABAVERT rabies vaccine with diluents, awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA). The $3,860.60 firm fixed price delivery order has a completion date of November 1, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026 to provide a comprehensive range of medical commodities,...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB25FDYMQ
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of RABAVERT rabies vaccine with diluents. The contract is a firm fixed-price delivery order with a ceiling value of $2,359.49 and a completion date of February 19, 2025. The contract is not designated with a set-aside.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. In addition, the company maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 5/20/25, 2:21 PM